Earlier this year, Dr. Mehmet Oz announced from his perch atop the Centers for Medicare and Medicaid Services that eligible Medicare Part D beneficiaries will be able to access select GLP-1 obesity medicines...
Voor onmiddellijke publicatie Amsterdam, Nederland — 12 juni 2026 — Een nieuwe peiling in opdracht van het Consumer Choice Center laat zien dat Nederlanders het recht van gewone burgers steunen...
Consumer Choice Center fordert Bundesregierung auf, zusätzliche Langstreckenflüge nach Berlin und Stuttgart endlich zu erlauben Berlin, 10. Juni 2026 — Das Consumer Choice Center fordert die Bundesregierung auf, zusätzliche Langstreckenverbindungen...
For patients with needle phobia, the arrival of oral GLP-1 weight-loss medicines is not a shortcut. It is an opening. The UAE’s approval of Foundayo, alongside the availability of oral...
The National Consumers League’s new issue brief is a useful and uncomfortable reminder that a program created to help vulnerable patients can drift far from its mission. Its core finding...
A striking pattern runs through the batch of French legislative proposals. The goals are all different. One bill is about apprenticeships. Another is about railway continuity. Others deal with housing,...
On Thursday, April 16, the Senate HELP Committee will hold a hearing titled Making Medicines More Affordable: How Competition Can Lower Drug Prices, featuring testimony from Brian J. Miller of...
For patients, medical innovation is not an abstract policy debate. It is more time, better treatment, less suffering, and a real chance at a longer, healthier life. That is the...
As the House Energy and Commerce Health Subcommittee meets on March 18, 2026, at 10:15 a.m. ET for the third hearing in its health care affordability series, lawmakers should look...
During his February 24 State of the Union address, President Trump took a victory lap on prescription drug prices. He touted “most favored nation” pricing, highlighted the TrumpRx website, and...
Over the last two decades, we have witnessed something genuinely unusual in public health: a medical breakthrough that has rapidly moved from specialist clinics into everyday conversation. GLP-1 drugs such...
At first glance, the 340B program sounds simple. Certain hospitals and clinics can buy medicines at much lower prices. The idea is that these lower prices help them support patients...
